Air Products & Chemicals financials
$278.75−1.07%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Sep 30 | FY24 Sep 30 | FY23 Sep 30 | FY22 Sep 30 | FY21 Sep 30 | FY20 Sep 30 | FY19 Sep 30 | FY18 Sep 30 | FY17 Sep 30 | FY16 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.04B | $12.10B | $12.60B | $12.70B | $10.32B | $8.86B | $8.92B | $8.93B | $8.19B | $7.50B |
| Gross profit | $3.78B | $3.93B | $3.77B | $3.36B | $3.14B | $3.00B | $2.94B | $2.74B | $2.44B | $2.33B |
| Gross margin | 31.4% | 32.5% | 29.9% | 26.5% | 30.4% | 33.9% | 33.0% | 30.7% | 29.8% | 31.0% |
| Operating income | -$944.3M | $2.89B | $2.49B | $2.28B | $2.21B | $2.20B | $2.17B | $1.97B | $1.59B | $1.57B |
| Net income | -$394.5M | $3.83B | $2.30B | $2.26B | $2.10B | $1.89B | $1.76B | $1.50B | $3.00B | $631.1M |
| Net margin | −3.3% | 31.6% | 18.3% | 17.8% | 20.3% | 21.3% | 19.7% | 16.8% | 36.6% | 8.4% |
| Diluted EPS | $-1.77 | $17.18 | $10.33 | $10.14 | $9.43 | $8.49 | $7.94 | $6.78 | $13.65 | $2.89 |
| EBITDA | $4.37B | $4.40B | $4.10B | $3.69B | $3.54B | $3.39B | $3.25B | $2.94B | $2.65B | $2.47B |
| Operating cash flow | $3.26B | $3.65B | $3.21B | $3.23B | $3.34B | $3.26B | $2.97B | $2.53B | $1.56B | $2.66B |
| Free cash flow | -$3.77B | -$3.15B | -$1.42B | $303.7M | $877.7M | $755.7M | $980.2M | $966.0M | $522.5M | $1.75B |
| Diluted shares | 222.7M | 222.8M | 222.7M | 222.5M | 222.5M | 222.3M | 221.6M | 220.8M | 219.8M | 218.3M |
Balance sheet
| Period end | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.86B | $2.98B | $1.62B | $2.71B | $4.47B | $5.25B |
| Short-term investments | $0.00 | $5.0M | $332.2M | $590.7M | $1.33B | $1.10B |
| Total debt | $17.70B | $14.23B | $10.16B | $6.99B | $7.36B | $7.61B |
| Total assets | $41.06B | $39.57B | $32.00B | $27.19B | $26.86B | $25.17B |
| Total liabilities | $23.71B | $20.90B | $16.34B | $13.49B | $12.77B | $12.73B |
| Shareholders' equity | $17.35B | $18.67B | $15.66B | $13.70B | $14.09B | $12.44B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology